CoChat

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect

Lee, Yena, Syeda, Kahlood, Maruschak, Nadia A., Cha, Danielle S., Mansur, Rodrigo B., Wium-Andersen, Ida K., Woldeyohannes, Hanna O., Rosenblat, Joshua D., McIntyre, Roger S. · 2016 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Available evidence indicates that a single, low-dose administration of ketamine is a robust, rapid-onset intervention capable of mitigating depressive symptoms in adults with treatment-resistant mood disorders. Additional evidence also suggests that ketamine may offer antisuicide effects. Herein, we propose that the antidepressant effects reported with ketamine administration are mediated, in part, by targeting neural circuits that subserve cognitive processing relevant to executive function and cognitive emotional processing. Empirical support for the conceptual framework of the cognitive domain as a critical target of ketamine's action is the additional observation that pretreatment cognitive function predicts treatment outcomes with ketamine administration. The proposal that beneficial effects on cognitive function may be, in some individuals, the proximate mechanism mitigating symptom relief in mood disorders exists alongside the well-established deleterious effect of ketamine on cognitive function. During the past 5 years, there have been several reviews and meta-analyses concluding that ketamine has possible clinical benefits in refractory mood disorders. We introduce the conceptual framework that ketamine's salutary effects, notably in suicidality, may in part be via procognitive mechanisms.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000000441

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 61 references

Cited by

See all 82

Metadata

Authors
Lee, Y., Syeda, K., Maruschak, N. A., Cha, D. S., Mansur, R. B., Wium-Andersen, I. K., Woldeyohannes, H. O., Rosenblat, J. D., & McIntyre, R. S.
Affiliations
  • University Health Network (CA)
  • University of Toronto (CA)
Corresponding author
  • Lee, Yena
  • Syeda, Kahlood
  • Maruschak, Nadia A.
  • Mansur, Rodrigo B.
  • Woldeyohannes, Hanna O.
  • Rosenblat, Joshua D.
  • McIntyre, Roger S.
Venue
Journal of Clinical Psychopharmacology
Published
2016-02
Volume
36
Issue
1
Pages
50-56
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2336185620
Cited by
74
References
61
Citations by year
2026: 1 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 11 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 2
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
Keywords
ketamine, treatment-resistant depression, mood disorders, cognitive function, executive function, neural circuits, mechanism of action
MeSH terms
Suicide Prevention, Adult, Cognition, Humans, Ketamine, Excitatory Amino Acid Antagonists, Mood Disorders, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect. https://app.cochat.ai/papers/10.1097/jcp.0000000000000441
The paper
Lee, Y., Syeda, K., Maruschak, N. A., Cha, D. S., Mansur, R. B., Wium-Andersen, I. K., Woldeyohannes, H. O., Rosenblat, J. D., & McIntyre, R. S. (2016). A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000441

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.